◆ 会议时间：2026年3月28-31日
◆ 会议地点：捷克 布拉格
◆ 会议简介：
2026年第34届欧洲精神病学大会(EPA2026)将于2026年3月28-31日在捷克布拉格举行，会议由欧洲最大的精神病学家协会——欧洲精神病学协会(EPA)主办。欧洲精神病学大会(EPA大会)是促进精神病学、心理学、社会工作和临床试验领域一系列主题进行讨论和教育的论坛，大会将汇集精神健康领域的临床医学专家、研究人员和相关者组织的领导者，并提供一系列杰出的全体会议、艺术讲座、教育课程、座谈会、研讨会、非正式专家会议以及为职业生涯早期的精神病学家设计的课程；预计有超过3000名来自世界各地的专业人士注册参会。
欧洲精神病学协会(EPA)成立于1983年，是代表欧洲精神病学的首要学会，其成员包括来自88个国家的活跃个人会员和44个代表超过80000名欧洲精神病科医师的国家级学会/协会成员，EPA成员包括众多领域宣的知名专家，他们共同为协会和欧洲精神病学的发展做出贡献。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
EPA 2026 - 34th European Congress of Psychiatry
Date:
28 – 31 March, 2026
Venue:
Prague Congress Centre
Prague, Czech Republic
Congress motto is “Mental Health: Improving Care and Expanding Horizons”
Organized by:
European Psychiatric Association (EPA)
摘要征文投稿：
Abstract Submissions
- Abstract submission opening:
26 June 2025
- Abstract submission deadline:
24 September 2025, 23:59 CEST
- Early bird registration deadline:
January 2026
点此提交摘要>>>Submit Abstract>>>
View the abstract topics here
Presentation type: Abstracts may be submitted for Oral Communication Session, e-Poster Presentation or e-Poster Viewing. The Scientific Programme Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility) or by a copy editor, prior to submission.
- Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced as submitted. No proofreading will be done. It is not possible to modify abstracts after the submission deadline.
- The work described in the abstract needs to have an appropriate approval under local, ethical and animal experimentation rules.
- Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Congress.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- The inclusion of trade names/brand names is not allowed in the abstract. Please use generic names of drugs. The mentioning of agents/molecules must follow the scientific standard for publications. The presentation must be balanced and contain no commercial promotional content.
Conflict of interest: It is the intent of EPA to provide high quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstract submission.
An abstract can only be submitted if the “Declaration” on the online abstract form is read and accepted.
Please note that each person may submit up to 5 abstracts as a presenting author. Whilst the Organisers will try to avoid scheduling conflicts, these might occur. In this case, one of the listed co-authors needs to take over the presentation.
Abstract typing instructions
For standardisation, the acceptable length of the abstract is limited to 3,000 characters and 45 lines, with authors’ details, headers and tables included. This also includes non-visible characters such as spaces as well as punctuation.
The abstract should be structured into the following sections:
- A title which clearly indicates the nature of the investigation
- Introduction
- Objectives
- Methods
- Results
- Conclusions
Up to three tables can be included in the Results section with the following criteria:
- Maximum number of columns: 10
- Maximum number of rows: 10
Tables count towards the total number of allowed characters and lines.
Up to three images/graphs can be included. They should be of high quality, and lettering/symbols/lines should be clear and distinct. Images will be reduced to one column width.
The system only accepts images that fulfil the following criteria:
- Image width: min. 50 pixels – max. 600 pixels
- Image height: min. 50 pixels – max. 800 pixels
- Image quality: min. 96 dpi – max. 300 dpi
- Image file size: min. 40 KB – max. 1000 KB
- Allowed file types: gif, jpg
All tables, figures, and reference citations must be referred to in the text of the abstract. If there is no reference in the text, the table/figure/reference (as applicable) will be removed from the abstract before publication.
If references are essential, they should be within the text, in the form: (Murphy et al. BJU Int 2005; 95 27-30).
We have the privilege to invite you to attend the 34th European Congress of Psychiatry, which will be held in Prague, Czech Republic, on 28 – 31 March 2026.
The 2026 Congress motto will be “Mental Health: Improving Care and Expanding Horizons”, emphasising the need to improve mental healthcare across all contexts and for every citizen living in Europe. “Expanding Horizons” underscores the importance of strengthening collaboration with allied professionals and including experts by experience and carers in the improvement of mental healthcare.
We hope that the Congress will broaden participants’ understanding of mental health by promoting a translational approach, bridging humanities with social sciences, and fostering dialogue between psychiatry and other medical disciplines.
The 2026 Congress will provide an excellent opportunity to share clinical knowledge, advance education, and discuss research opportunities in the areas of prevention, early detection, diagnosis and treatment of mental disorders, as well as in the promotion of mental health in the general population.
The European Psychiatric Association includes 44 National Psychiatric Associations, representing more than 80,000 mental health professionals across Europe. In addition to its 23 Scientific Sections, the Associations also includes several Committees and Task Forces dedicated to addressing key challenges in mental health. Participating in the 2026 Congress will be a unique opportunity to gain new insights, optimise patient care, and expand professional networks.
The Congress will be hosted in the wonderful city of Prague, located in the heart of Europe, offering a perfect blend of tradition and innovation.
We look forward to welcoming you to Prague at the 34th European Congress of Psychiatry!
Andrea Fiorillo
EPA President 2025 - 2027
Tomáš Kašpárek
Chair of the EPA 2026
Local Organising Committee
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
